ArrowMark Colorado Holdings’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13M | Sell |
|
|||||
|
2025
Q1 | $7.51M | Sell |
|
|||||
|
2024
Q4 | $11.3M | Buy |
|
|||||
|
2024
Q3 | $13.9M | Buy |
|
|||||
|
2024
Q2 | $9M | Sell |
|
|||||
|
2024
Q1 | $20.8M | Sell |
|
|||||
|
2023
Q4 | $16M | Buy |
|
|||||
|
2023
Q3 | $9.98M | Buy |
|
|||||
|
2023
Q2 | $11M | Buy |
|
|||||
|
2023
Q1 | $1.46M | Sell |
|
|||||
|
2022
Q4 | $3.08M | Sell |
|
|||||
|
2022
Q3 | $1.74M | Sell |
|
|||||
|
2022
Q2 | $5.75M | Hold |
|
|||||
|
2022
Q1 | $6.85M | Sell |
|
|||||
|
2021
Q4 | $27.9M | Buy |
|
|||||
|
2021
Q3 | $26.1M | Buy |
|
|||||
|
2021
Q2 | $18.1M | Sell |
|
|||||
|
2021
Q1 | $25.2M | Sell |
|
|||||
|
2020
Q4 | $35.6M | Buy |
|
|||||
|
2020
Q3 | $24.9M | Buy |
|
|||||
|
2020
Q2 | $8.83M | Buy |
|